Welcome to our dedicated page for Integral Ad Science Holding SEC filings (Ticker: IAS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Integral Ad Science Holding Corp. (historically trading under the symbol IAS on the Nasdaq Global Select Market) provide a detailed record of its financial performance, corporate actions, and the transaction that took the company private. These documents are central for understanding IAS's historical operations as a media measurement and optimization platform focused on digital advertising quality, brand safety, and transparency.
Investors and researchers can use IAS’s annual reports on Form 10-K and quarterly reports on Form 10-Q to review condensed consolidated financial statements, including revenue categories such as optimization revenue, measurement revenue, and publisher revenue. These filings also describe operating expenses, stock-based compensation, internal use software development, goodwill and intangible assets, and other elements that reflect IAS’s scale as a technology-driven media measurement business.
Current reports on Form 8-K capture material events and strategic milestones. For example, Forms 8-K filed on September 24, 2025 and December 23, 2025 describe the Agreement and Plan of Merger with an affiliate of Novacap Management Inc. and the subsequent completion of the merger. The December 23, 2025 filing explains that a Novacap-affiliated acquisition subsidiary merged with and into IAS, that IAS became a wholly owned subsidiary of the acquiring parent, and that each share of IAS common stock (with specified exceptions) was converted into the right to receive cash. The same filing discusses IAS’s request to delist its common stock from Nasdaq via Form 25 and its intention to file Form 15 to terminate registration and suspend Exchange Act reporting obligations.
Other 8-K filings document items such as amendments to credit agreements, creation or termination of credit facilities, and the announcement of quarterly financial results. Together, these filings trace IAS’s capital structure, debt arrangements, and key financial disclosures over time.
On Stock Titan’s IAS filings page, users can access these historical SEC documents and benefit from AI-powered summaries that explain the contents of lengthy forms, including 10-Ks, 10-Qs, and 8-Ks, in more accessible language. Real-time updates from EDGAR ensure that material events such as mergers, delistings, and changes in control are reflected promptly. In addition, Form 4 and other ownership-related filings, where available, can help users analyze historical insider equity awards and transactions during the period when IAS was publicly traded.
Because IAS has completed a merger and moved to delist and deregister its common stock, the SEC filings now serve primarily as a historical record of its time as a public company, its financial trajectory, and the terms under which it became a privately held subsidiary of a Novacap-affiliated entity.
Insider sale under Rule 10b5-1: An officer of Integral Ad Science Holding Corp. (IAS) reported a sale of 3,527 shares of common stock on
The Form 4 was signed by an authorized representative on
Integral Ad Science Holding Corp. (IAS) chief executive and director reported the vesting and partial sale of equity awards on
Integral Ad Science Holding Corp. insider notice reports a proposed sale of 9,264 common shares held through a restricted stock vesting event on
Integral Ad Science Holding Corp. (IAS) reporting person Gil Alexis II, Chief Accounting Officer, executed a mandatory sale of 1,992 shares of common stock on
IAS (Form 144): A notice was filed for the proposed sale of 17,267 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $176,019.80. The approximate sale date is 10/03/2025 on NASDAQ.
The shares were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation, in the same amount of 17,267 shares. Shares outstanding were 166,163,514.
Recent activity disclosed for the same seller, Lisa M. Utzschneider, includes sales of 14,904 shares for $123,850.75 on 07/08/2025, 8,285 shares for $68,666.08 on 07/10/2025, and 9,922 shares for $80,523.98 on 08/06/2025.
Integral Ad Science Holding Corp. (IAS) insider filing on Form 144 notifies the market that 3,527 common shares are proposed for sale through Fidelity Brokerage Services LLC on 10/03/2025 on NASDAQ, with an aggregate market value of $35,904.86. The shares were acquired by Restricted Stock Vesting on 10/01/2025 and are noted as compensation. The filer also disclosed four prior sales during the past three months, including a sale of 25,901 shares on 09/24/2025 that generated $263,771.71. The form includes the filer representation that they are not aware of undisclosed material adverse information about the issuer.
Lisa Utzschneider, Chief Executive Officer and director of Integral Ad Science Holding Corp. (IAS), reported the acquisition of 33,870 shares of common stock on 10/01/2025 through the vesting of market stock units (MSUs) granted April 1, 2024. The shares were recorded at a $0 purchase price because they were issued on vesting. After the transaction, Ms. Utzschneider beneficially owned 414,427 shares of common stock directly and held derivative interests (MSUs) underlying 33,870 additional shares, bringing total derivative-related beneficial ownership to 802,182 shares.
The MSUs reported represent the maximum possible payout (up to 225% of target) and have a minimum payout threshold of 60%. Vesting occurs 25% on April 1, 2025 and then in equal quarterly installments over three years, subject to continued employment. The Form 4 was signed on behalf of the reporting person by power of attorney on 10/02/2025.
Integral Ad Science Holding Corp. (IAS) Form 144 notice reports a proposed sale of 1,992 common shares through Fidelity Brokerage Services LLC on or about 10/02/2025, with an aggregate market value of $20,280.15. The filer states these shares were acquired on 10/01/2025 through restricted stock vesting and the payment type is listed as compensation. The filing also discloses three prior open-market sales by the same person: 1,962 shares on 07/07/2025 for $16,539.47, 2,784 shares on 09/03/2025 for $24,995.59, and 25,901 shares on 09/24/2025 for $263,771.71. The form notes 166,163,514 shares outstanding for the issuer and includes the required representation that the seller is not aware of undisclosed material adverse information.
Gil Alexis II, Chief Accounting Officer of Integral Ad Science Holding Corp. (IAS), reported a sale of 25,901 shares of common stock on 09/24/2025. The sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025. The price reported is a weighted average of $10.18 per share, with individual sale prices ranging from $10.18 to $10.20 per share. Following the reported transaction, the reporting person beneficially owned 145,140 shares. The Form 4 was signed on behalf of the reporting person by power of attorney on 09/26/2025.
Integral Ad Science Holding Corp. entered into an Agreement and Plan of Merger dated September 24, 2025, under which Igloo Group Acquisition Company, a Novacap-affiliated Merger Sub, will merge into the company and the company will become a wholly owned subsidiary of Igloo Group Parent, Inc.
Each outstanding share of company common stock (other than excluded shares) will be converted into the right to receive $10.30 in cash. Outstanding options, RSUs and MSUs are addressed: in-the-money options will be cashed out for the spread, unvested RSUs convert to contingent cash awards that retain original vesting conditions, and MSUs convert into replacement MSU awards in the acquirer with vesting tied to continued service and original settlement schedules.
Closing conditions include stockholder consents and customary conditions, a required mailing at least 20 days before closing, and the closing will not occur before November 23, 2025 without Parent consent. A Support Agreement with Vista Equity-affiliated funds provides that certain stockholders agreed to vote in favor of the Merger. The Form 8-K is signed by CFO Alpana Wegner.
FAQ
What is the current stock price of Integral Ad Science Holding (IAS)?
What is the market cap of Integral Ad Science Holding (IAS)?
